
Switching space...
Please wait while we prepare your workspace
Celeos SAS is developing a molecular real-time cancer diagnosis device to empower clinicians and improve cancer care. Their SpiderMass technology analyzes samples to get their molecular specific profiles, like a fingerprint. This solution allows for saving and contactless in situ sampling by laser, molecular analysis by mass spectrometry, and an explainable real-time AI framework to provide powerful tissue characterization and precise surgical margin definition.
FOUNDATION
YEAR2022
YEAR2022
EMPLOYEESN/A
AVERAGE AGEN/A